Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratedWith |
gptkb:AbbVie
|
| gptkbp:developedBy |
monoclonal antibodies
|
| gptkbp:focusesOn |
immuno-oncology
autoimmune diseases |
| gptkbp:foundedYear |
2017
|
| gptkbp:headquartersLocation |
gptkb:United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Trishula Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
TST001
|
| gptkbp:TST001Target |
Claudin 18.2
|
| gptkbp:website |
https://www.trishulatherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Versant_Ventures
|
| gptkbp:bfsLayer |
7
|